Alcohol's Dysregulation of Maternal-Fetal IL-6 and p-STAT3 Is a Function of Maternal Iron Status

Nipun Saini1, Kaylee K Helfrich1, Sze Ting Cecilia Kwan1

  • 1Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, North Carolina.

Insights

Prenatal alcohol exposure (PAE) disrupts iron regulation by activating the IL-6/JAK2/STAT3 pathway. A prenatal iron-fortified (IF) diet normalizes these changes, suggesting IF as a potential therapy for PAE-related deficits.

Area of Science:

  • Biochemistry
  • Developmental Biology
  • Toxicology

Background:

  • Prenatal alcohol exposure (PAE) leads to growth and neurodevelopmental issues, exacerbated by maternal iron deficiency (ID).
  • PAE induces fetal anemia, brain ID, and elevated hepatic iron through increased hepcidin synthesis.
  • A prenatal iron-fortified (IF) diet can normalize these PAE-induced changes.

Purpose of the Study:

  • To investigate how iron status and PAE affect the EPO/BMP6/SMAD and IL-6/JAK2/STAT3 pathways governing hepcidin production.
  • To determine the efficacy of an iron-fortified diet in mitigating PAE-induced hepcidin dysregulation.

Main Methods:

  • Pregnant rats were fed iron-deficient (ID), iron-sufficient (IS), or iron-fortified (IF) diets.
  • Alcohol or maltodextrin was administered daily during late gestation (GD 13.5-19.5).
  • Hepatic protein and gene expression, including hepcidin regulators, were analyzed at GD 20.5.

Main Results:

  • PAE reduced SMAD signaling but increased IL-6 expression and STAT3 activation in maternal and fetal liver.
  • Fetal cytokine responses to PAE were less pronounced than in dams.
  • Dietary iron fortification significantly reduced IL-6 expression and normalized STAT3 activation in response to PAE.

Conclusions:

  • Alcohol-induced hepcidin elevation in PAE is mediated by the IL-6/JAK2/STAT3 pathway.
  • Iron fortification normalizes these signaling pathways, suggesting it counteracts alcohol's effects on hepcidin.
  • Prenatal iron fortification shows promise as a therapeutic strategy for PAE.
Abstract

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...